Sensitivity to radiofrequency fields / electrosensitivity Mental and Behavioural Disorders Sensitivity to radiofrequency fields / electrosensitivity
Conditions
Interventions
Each participant will be exposed to each of three conditions: pulsed 900 MHz GSM radiofrequency fields, unpulsed radiofrequency fields of the same mean power, and a sham (placebo) condition. Each of t
Sponsors
Mobile Telecommunications and Health Research programme (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Two samples will be tested, consisting of 'control' and 'sensitive' participants. To be eligible for the sensitive group, participants must report experiencing often headaches within 20 min of using a GSM mobile phone. Only participants who do not attribute any symptoms to mobile phone signals will be eligible for inclusion in the control group.
Exclusion criteria
Exclusion criteria: Participants will be excluded if: under 18, over 75, pregnant, suffering from a psychotic illness, currently using antidepressants, or if they report severe symptoms at baseline while in the testing room.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Our primary outcome will consist of self-reported headache severity during exposure, recorded using a 0-100 mm visual analogue scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes will include: self-reported severity for nausea, fatigue, dizziness, skin itching, tingling or stinging, sensations of warmth or burning on skin, and eye pain or dryness. Neuroendocrine outcomes will include: plasma levels of cortisol, adrenocorticotropic hormone, growth hormone and prolactin. Secondary outcomes will be recorded during each of the three experimental provocations. | — |
Countries
United Kingdom
Outcome results
None listed